SG Americas Securities’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-128,745
| Closed | -$3.82M | – | 3589 |
|
|
2023
Q4 | $3.82M | Buy |
128,745
+40,530
| +46% | +$807K | 0.04% | 416 |
|
|
2023
Q3 | $1.4M | Buy |
88,215
+47,467
| +116% | +$789K | 0.02% | 995 |
|
|
2023
Q2 | $769K | Sell |
40,748
-5,976
| -13% | -$70.6K | 0.01% | 1194 |
|
|
2023
Q1 | $179K | Buy |
46,724
+9,419
| +25% | +$40.1K | ﹤0.01% | 2513 |
|
|
2022
Q4 | $185K | Sell |
37,305
-4,371
| -10% | -$23.7K | ﹤0.01% | 2256 |
|
|
2022
Q3 | $199K | Sell |
41,676
-137,395
| -77% | -$724K | ﹤0.01% | 2325 |
|
|
2022
Q2 | $806K | Buy |
+179,071
| New | +$778K | 0.01% | 1500 |
|
|
2022
Q1 | – | Sell |
-35,436
| Closed | -$263K | – | 3576 |
|
|
2021
Q4 | $263K | Sell |
35,436
-90,394
| -72% | -$562K | ﹤0.01% | 2522 |
|
|
2021
Q3 | $713K | Buy |
125,830
+111,393
| +772% | +$644K | ﹤0.01% | 2205 |
|
|
2021
Q2 | $95K | Sell |
14,437
-173,955
| -92% | -$1.21M | ﹤0.01% | 2695 |
|
|
2021
Q1 | $1.53M | Buy |
188,392
+157,323
| +506% | +$1.28M | 0.01% | 1234 |
|
|
2020
Q4 | $200K | Sell |
31,069
-298,458
| -91% | -$1.74M | ﹤0.01% | 2629 |
|
|
2020
Q3 | $1.19M | Buy |
329,527
+272,094
| +474% | +$1.1M | 0.01% | 1079 |
|
|
2020
Q2 | $264K | Sell |
57,433
-66,156
| -54% | -$281K | ﹤0.01% | 2617 |
|
|
2020
Q1 | $421K | Buy |
123,589
+103,014
| +501% | +$450K | ﹤0.01% | 1978 |
|
|
2019
Q4 | $105K | Sell |
20,575
-211,632
| -91% | -$718K | ﹤0.01% | 2939 |
|
|
2019
Q3 | $562K | Buy |
232,207
+222,004
| +2,176% | +$589K | ﹤0.01% | 1812 |
|
|
2019
Q2 | $22K | Buy |
+10,203
| New | +$24.1K | ﹤0.01% | 2984 |
|
|
2018
Q3 | – | Sell |
-11,801
| Closed | -$115K | – | 3522 |
|
|
2018
Q2 | $115K | Buy |
+11,801
| New | +$124K | ﹤0.01% | 2987 |
|
|
2018
Q1 | – | Sell |
-18,416
| Closed | -$118K | – | 3621 |
|
|
2017
Q4 | $118K | Buy |
18,416
+7,937
| +76% | +$49K | ﹤0.01% | 2770 |
|
|
2017
Q3 | $80K | Buy |
+10,479
| New | +$69.6K | ﹤0.01% | 3244 |
|
|
2016
Q4 | – | Sell |
-33,370
| Closed | -$89K | – | 3546 |
|
|
2016
Q3 | $89K | Buy |
+33,370
| New | +$97K | ﹤0.01% | 3099 |
|
|
2016
Q2 | – | Sell |
-13,735
| Closed | -$117K | – | 3068 |
|
|
2016
Q1 | $117K | Buy |
+13,735
| New | +$116K | ﹤0.01% | 2533 |
|
|
2015
Q4 | – | Sell |
-11,778
| Closed | -$113K | – | 3043 |
|
|
2015
Q3 | $113K | Sell |
11,778
-4,843
| -29% | -$70.8K | ﹤0.01% | 1791 |
|
|
2015
Q2 | $239K | Buy |
+16,621
| New | +$183K | ﹤0.01% | 1898 |
|
|
2015
Q1 | – | Sell |
-20,199
| Closed | -$123K | – | 3153 |
|
|
2014
Q4 | $123K | Buy |
20,199
+10,523
| +109% | +$96.2K | ﹤0.01% | 2776 |
|
|
2014
Q3 | $102K | Buy |
+9,676
| New | +$109K | ﹤0.01% | 2371 |
|
|
2013
Q4 | – | Sell |
-18,517
| Closed | -$315K | – | 3089 |
|
|
2013
Q3 | $315K | Buy |
+18,517
| New | +$325K | ﹤0.01% | 1898 |
|
Other funds holding IMGN
SG Americas Securities's IMGN Position: Q1 2024 in Review
SG Americas Securities sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 128,745 shares — an estimated $3.82M sold.
SG Americas Securities first reported a position in IMGN in Q3 2013 and held it in 28 quarters. The position peaked at $3.82M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- SG Americas Securities reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- SG Americas Securities sold 128,745 Immunogen Inc shares in Q1 2024, an estimated $3.82M.
- SG Americas Securities first reported a position in Immunogen Inc in Q3 2013 and held it in 28 quarters.
- SG Americas Securities's Immunogen Inc position peaked at $3.82M in Q4 2023.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.